Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
BIOEarnings Release财报快讯Media source媒体来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

BIO earnings release — EPS beat +18.8% · revenue in line +1.0%Bio Rad实验室 (BIO) 财报发布 — EPS 高于预期+18.8% · 营收 基本符合预期+1.0%

Key Results

Actual vs Consensus

  • EPS: $2.65 vs $2.23 estimate, beat+18.8%.
  • Revenue: $656M vs $650M estimate, in line+1.0%.

    • Profitability and Cash Flow

  • Period: 2026 Q3 period ended 2026-09-30
  • Revenue: $656M; YoY: +0.5%; QoQ: +0.8%
  • Gross profit: $329M; Gross margin: 50.1%
  • Operating income: -$50M; Operating margin: -7.6%
  • Net income: $459M; GAAP diluted EPS: $17.02; YoY: +234.1%; QoQ: +23.5%
  • Operating cash flow: $96M; Capex: $31M; Free cash flow: $65M

    • Official release: Bio-Rad Reports Third-Quarter 2026 Financial Results

    核心结果

    实际值与市场预期

  • EPS：$2.65 vs $2.23 预期，高于预期+18.8%。
  • 营收：$656M vs $650M 预期，基本符合预期+1.0%。

    • 财务指标

  • 期间：2026 Q3（截至 2026-09-30）
  • 营收：$656M；同比：+0.5%；环比：+0.8%
  • 毛利润：$329M；毛利率：50.1%
  • 经营利润：-$50M；经营利润率：-7.6%
  • 净利润：$459M；GAAP 稀释 EPS：$17.02；同比：+234.1%；环比：+23.5%
  • 经营现金流：$96M；资本开支：$31M；自由现金流：$65M
    • View BIO stock details ->查看 BIO 个股详情 ->

    For information only. Not investment advice.内容仅供参考，不构成投资建议。